{"id":3970,"date":"2022-11-08T15:10:27","date_gmt":"2022-11-08T15:10:27","guid":{"rendered":"https:\/\/www.impactafricasummit.org\/?page_id=3970"},"modified":"2022-11-08T15:10:27","modified_gmt":"2022-11-08T15:10:27","slug":"dr-carolyn-hoppe","status":"publish","type":"page","link":"https:\/\/www.impactafricasummit.org\/pias\/ias-pharma-2022-speakers\/dr-carolyn-hoppe\/","title":{"rendered":"Dr. Carolyn Hoppe"},"content":{"rendered":"<div id=\"mediapat\">\n<div class=\"mdpatleft\">\n<img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/www.impactafricasummit.org\/wp-content\/uploads\/2022\/11\/Dr-Carolyn-Hoppe.png\" alt=\"Dr. Carolyn Hoppe\" class=\"alignnone size-full wp-image-3971\" srcset=\"https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Dr-Carolyn-Hoppe.png 500w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Dr-Carolyn-Hoppe-300x300.png 300w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Dr-Carolyn-Hoppe-150x150.png 150w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Dr-Carolyn-Hoppe-200x200.png 200w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Dr-Carolyn-Hoppe-100x100.png 100w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/>\n<\/div>\n<div class=\"mdpatright\">\n<h2>Dr. Carolyn Hoppe<\/h2>\n<p class=\"mdpat\">Senior Medical Director, Clinical Lead<br \/>\nGlobal Blood Therapeutics (PFIZER)<\/p>\n<p>Dr. Carolyn Hoppe is Senior Medical Director and Clinical Lead for the Inclacumab THRIVE studies at Global Blood Therapeutics. Carolyn is also a hematologist by training and prior to joining GBT, she enjoyed a 20-year career as Professor of Pediatrics in Hematology-Oncology at University of California San Francisco (UCSF) Benioff Children\u2019s Hospital in Oakland.  She is excited to share her clinical experience and expertise in sickle cell disease and contribute to the development of new therapies for SCD.   <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Carolyn Hoppe Senior Medical Director, Clinical Lead Global Blood Therapeutics (PFIZER) Dr. Carolyn Hoppe is Senior Medical Director and Clinical Lead for the Inclacumab THRIVE studies at Global Blood Therapeutics. Carolyn is also a hematologist by training and prior to joining GBT, she enjoyed a 20-year career as Professor of Pediatrics in Hematology-Oncology at [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2531,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3970","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/3970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/comments?post=3970"}],"version-history":[{"count":1,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/3970\/revisions"}],"predecessor-version":[{"id":3972,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/3970\/revisions\/3972"}],"up":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/2531"}],"wp:attachment":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/media?parent=3970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}